The DOI matches its Crossref record; 1,505 of the 1,505 references it cites were found in a registry or an index.
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Intrinsic Motivation and Self-Determination in Human Behavior
Deci, E. L., & Ryan, R. M. (1985) · doi:10.1007/978-1-4899-2271-7 · Cited by 26,772
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Research works printed but not linked: 40
- 10) Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816
- 11) Mizuta R, Kubota Y, Takeshita S, Akutsu K, Nakamoto F, Tanaka N, Sano M, Okajima T, Tsutsumi Y: Transit Time of Vessel Flow in Below-knee is Useful for Screening of Vessel in Below-knee Lesions. Jpn J Med Ultrasound Technology, 2009; 34: 543-547
- 13) Japanese Society of Nephrology: Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Clin Exp Nephrol, 2019; 23: 1-15 · doi:10.1007/s10157-018-1648-1
- 14) Subcommittee for preparing guidelines on ultrasound diagnosis of renal arteries. Guidelines on methods of standard assessment of ultradound diagnosis of renal arterial lesions. Jpn J Med Ultrasonics, 2015;42:185-200 (in Japanese)
- 104) Higashiyama A, Wakabayashi I, Okamura T, Kokubo Y, Watanabe M, Takegami M, Honda-Kohmo K, Okayama A, Miyamoto Y: The Risk of Fasting Triglycerides and its Related Indices for Ischemic Cardiovascular Diseases in Japanese Community Dwellers: the Suita Study. J Atheroscler Thromb, 2021; 28: 1275-1288 · DOI
- 142) Miida T, Hirayama S: Controversy over the atherogenicity of lipoprotein-X. Curr Opin Endocrinol Diabetes Obes, 2019; 26: 117-123 · doi:10.1097/med.0000000000000466
- 245) Tanaka K, Hara S, Kushiyama A, Ubara Y, Yoshida Y, Mizuiri S, Aikawa A, Kawatzu S: Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol, 2011; 15: 391-397 · doi:10.1007/s10157-011-0420-6
- 272) Subcommittee for Renal Health Examination, Committee on Renal Disease Control, Japanese Society of Nephrology: Health guidance for the examinees of kidney medical checkup and suggestions to the referral criteria to medical institutions, Jpn J Nephrol 2017;59:38-42 (in Japanese)
- 291) Li R, Bensen JT, Hutchinson RG, Province MA, Hertz-Picciotto I, Sprafka JM, Tyroler HA: Family risk score of coronary heart disease (CHD) as a predictor of CHD: the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI family heart study. Genet Epidemiol, 2000; 18: 236-250 · doi:10.1002/(sici)1098-2272(200003)18:3<236::aid-gepi4>3.0.co;2-0
- 327) National Institute of Alcohol Abuse and Alcoholism: NIAAA council approves definition of binge drinking., 2004;3:3
- 328) Higuchi S: Promotion of Terms and Research, Alcohol and Health Impairment Countermeasures Conference Materials, Ministry of Health, Labour and Welfare, 2015 (in Japanese)
- 385) Tanemoto M, Saitoh H, Satoh F, Satoh H, Abe T, Ito S: Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens Res, 2005; 28: 237-242 · doi:10.1291/hypres.28.237
- 411) Woo J, Leung J: Does measurement of ankle-brachial index contribute to prediction of adverse health outcomes in older Chinese people? Intern Med J, 2013; 43: 1017-1023 · doi:10.1111/imj.12101
- 412) Wang Y, Guo X, Li J, Hu D, Zhao D, Ma H, Mou Q, Liu J, Xu Y: Predictive value of ankle-brachial index to all-cause mortality and cardiovascular mortality in Chinese patients with chronic kidney disease. Vasa, 2012; 41: 205-213 · doi:10.1024/0301-1526/a000187
- 580) Okubo K, Kiyohara Y.: Frequency of the metabolic syndrome in the general inhabitant. Rinsho to Kenkyu, 2004; 81: 1736-1740
- 582) Matsuzawa Y, Inoue S, Ikeda Y, Sakata T, Saitou Y,Satoh H, Shirai A, Oono J, Miyazaki S, Tokunaga M,Fukagawa H, Yamanouchi K, Nakamura M.: New evaluation of obesity and diagnostic criteria of obesity. J Jpn Soc Study of Obesity, 2000; 6: 18-28, in Japanese
- 584) Saito Y, Shirai K, Nakamura T: Diagnostic criteria for obesity. J Jpn Soc Study of Obesity, 2011; 17: 1-78 (in Japanese)
- 609) Okuda N, Kadota A, Nishi N, Miura K, Ohkubo T, Miyagawa N, Satoh A, Kita Y, Hayakawa T, Takashima N, Fujiyoshi A, Okayama A, Okamura T, Ueshima H: Association of Work Situation With Cardiovascular Disease Mortality Risk Among Working-Age Japanese Men - A 20-Year Follow-up of NIPPON DATA90. Circ J, 2019; 83: 1506-1513 · doi:10.1253/circj.cj-18-1067
- 634) Yuzuriha T: Early Intervention Programs for Alcohol-Related Problems, HAPPY. Journal of clinical and experimental medicine, 2007; 9: 728-732
- 1067) Izquierdo M, Merchant RA, Morley JE, Anker SD, Aprahamian I, Arai H, Aubertin-Leheudre M, Bernabei R, Cadore EL, Cesari M, Chen LK, De Souto Barreto P, Duque G, Ferrucci L, Fielding RA, García-Hermoso A, Gutiérrez-Robledo LM, Harridge SDR, Kirk B, Kritchevsky S, Landi F, Lazarus N, Martin FC, Marzetti E, Pahor M, Ramírez-Vélez R, Rodriguez-Mañas L, Rolland Y, Ruiz JG, Theou O, Villareal DT, Waters DL, Won CW, Woo J, Vellas B, Singh MF: International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J Nutr Health Aging, 2021; 25: 824-853 · DOI · Paper page
- 1084) Albert B: Social learning theory Englewood Cliffs, N.J. : Prentice Hall, 1977
- 1103) Noguchi M, Kojima S, Sairenchi T, Kinuta M, Yamakawa M, Nishizawa H, Takahara M, Imano H, Kitamura A, Yoshida T, Shintani A, Saito I, Yokoyama T, Shimomura I, Iso H: Japan Trial in High-Risk Individuals to Enhance Their Referral to Physicians (J-HARP)-A Nurse-Led, Community-Based Prevention Program of Lifestyle-Related Disease. J Epidemiol, 2020; 30: 194-199 · doi:10.2188/jea.je20180194
- 1188) Fruchart JC, Brewer HB, Jr., Leitersdorf E: Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group. Am J Cardiol, 1998; 81: 912-917
- 1225) Cybulska B, Kłosiewicz-Latoszek L: How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice? Kardiol Pol, 2018; 76: 1217-1223 · doi:10.5603/kp.a2018.0150
- 1233) Omar MA, Wilson JP, Cox TS: Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother, 2001; 35: 1096-1107 · doi:10.1345/1542-6270(2001)035<1096:rahcri>2.0.co;2
- 1266) Tanaka S, Ikari Y, Ijichi T, Nakazawa G: Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention. Cardiovasc Interv Ther, 2017; 32: 358-364 · doi:10.1007/s12928-016-0419-8
- 1305) Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T: Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet, 2019; 394: 131-138
- 1314) Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med, 2013; 369: 145-154
- 1360) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407 · doi:10.1016/j.atherosclerosis.2010.11.005
- 1379) Harada-Shiba M, Arisaka O, Ohtake A, Okada T, Suganami H: Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia. J Atheroscler Thromb, 2016; 23: 48-55 · doi:10.5551/jat.28753
- 1443) Bell S, Cooney J, Packard CJ, Caslake MJ, Deighan CJ: The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria. Clin Nephrol, 2012; 77: 445-453 · doi:10.5414/cn107450
- 1444) Yanai H: Hyperlipidemia due to Nephrotic Syndrome: Its Effects and Effects of Interventions on Atherogenesis, Cardiovascular and Renal Outcomes. J Endocrinol Metab, 2020; 10: 63-73 · doi:10.14740/jem663
- 1449) Alawami M, Wimalasena S, Ghashi R, Alnasrallah B: Acute arterial cardiovascular events risk in patients with primary membranous nephropathy. Intern Med J, 2019; 49: 855-858 · doi:10.1111/imj.14146
- 1460) Rofougaran R, Mooraki A, Bastani B: Insulin-requiring diabetes mellitus, hyperlipidemia, and anginal chest pains as prominent features of pheochromocytoma. Am J Nephrol, 1997; 17: 474-476 · doi:10.1159/000169145
- 1461) Winocour PH, Masud T, Clark F, Cooper BG, Laker MF, Alberti KG: Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study. Postgrad Med J, 1992; 68: 371-375 · doi:10.1136/pgmj.68.799.371
- 1462) Yamamoto M, Hosokawa T, Suehiro T, Numata S, Yamano T, Ono F: [A case of pheochromocytoma with hyper-HDL-cholesterolemia]. Nihon Naika Gakkai Zasshi, 1991; 80: 1678-1679 · doi:10.2169/naika.80.1678
- 1463) Ueda S, Morimoto T, Ando S, Takishita S, Kawano Y, Shimamoto K, Ogihara T, Saruta T: A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study. BMJ Open, 2014; 4: e004576 · doi:10.1136/bmjopen-2013-004576
- 1469) McDiarmid SV, Gornbein JA, Fortunat M, Saikali D, Vargas JH, Busuttil RW, Ament ME: Serum lipid abnormalities in pediatric liver transplant patients. Transplantation, 1992; 53: 109-115 · doi:10.1097/00007890-199201000-00021
- 1552) Kobayashi Y, Sugihara S, Tanaka Y, Ishihara H, Ohno K, Fujita H, Takizawa N, Tsuchihashi M: A consideration on criteria for blood collection after a meal in medical examinations of life-style related diseases in children. The Journal of the Japan Peiatric Society, 2011; 115: 1255-1264 (in Japanese)
- 1553) Dobashi K: Changes in Serum Cholesterol in Childhood and its Tracking to Adulthood. J Atheroscler Thromb, 2022; 29: 5-7 · doi:10.5551/jat.ed163
Cited by
Numakura, K., Kagaya, H., Yamamoto, R., Komine, N., Saito, M., Hiroshi, T., Akihama, S., Inoue, T., Narita, S., Tsuchiya, N., et al. (2015) · Disease Markers · doi:10.1155/2015/179434 · Cited by 14
Arai, H., Yamashita, S., Araki, E., Yokote, K., Tanigawa, R., Saito, A., Yamasaki, S., Suganami, H., & Ishibashi, S. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64677 · Cited by 8
Self-citationTsushima, R., Ito, A., Oishi, M., Ishihara, K., Iino, K., Tanaka, K., & Yokoyama, Y. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15072634
Widjaja, J. S., Adji, A. S., Baraja, A., Dharmasaputra, A., Rosyadi, R. N., Komalasari, I., Mustofa, A., Multazam, C. E. C. Z., Alkaff, F. F., & Saputra, P. B. T. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179420
Kasahara, H., Ikeda, M., Makioka, K., Nakamura, T., Takahashi, R., Kawarabayashi, T., Sanada, E., Suto, T., Higuchi, T., Tsushima, Y., et al. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251316516
Self-citation
Metadata
- Authors
- Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., Yoshida, M., Deguchi, J., Dobashi, K., Fujiyoshi, A., Hamaguchi, H., Hara, M., Harada-Shiba, M., Hirata, T., Iida, M., Ikeda, Y., Ishibashi, S., Kanda, H., Kihara, S., Kitagawa, K., Kodama, S., Koseki, M., Maezawa, Y., Masuda, D., Miida, T., Miyamoto, Y., Nishimura, R., Node, K., Noguchi, M., Ohishi, M., Saito, I., Sawada, S., Sone, H., Takemoto, M., Wakatsuki, A., & Yanai, H.
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2024-06-01
- Volume
- 31
- Issue
- 6
- Pages
- 641-853
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- OpenAlex
- W4292114749
- Cited by
- 302
- References
- 1,505
- FWCI
- 57.24
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. https://app.cochat.ai/papers/10.5551/jat.gl2022
- The paper
- Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., Yoshida, M., Deguchi, J., Dobashi, K., Fujiyoshi, A., Hamaguchi, H., Hara, M., Harada-Shiba, M., Hirata, T., Iida, M., . . . Yanai, H. (2024). Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.gl2022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.